lec 12-13 vaccines and bioterrorism Flashcards
Jenner 1796
first innoculation
smallpox
major uses of vaccines
domesticated livestock
pets
fish
wild animals
impact of vaccines on smallpox
eradicated
last case 1970s
impact of vaccines on diptheria
very effective
massive/rapid decline in incidence(1950)
impact of vaccines on polio
close to eradication
oral vaccine very effective
aiming to stop transmission e.g. in india
vaccines are not available for ….
malaria
tb
HIV
schistosomiasis
if the body shows natural immunity - recovers and becomes resistant to re-infection…
then it is feasible to devise a vaccine
e.g. polio, smallpox
when is it difficult to devise a vaccine
if the body recovers but is not resistant to re-infection
e.g. HIV, malaria, TB, gonorrhoeae
protective responses -antibodies
proteins that circulate in the blood - produced by B-lymphocytes
orchestrate immune response
bind to toxins, viruses or bacteria
neutralise or promote their clearance
4 types of vaccines
live attenuated
killed
sub-unit
naked DNA
live, attenuated vaccines
living but cannot cause disease
induce variety of immune responses
potential for reversion - virus becomes virulent again
examples of live attenuated vaccines
BCG polio yellow fever typhoid smallpox
why do live attenuated vaccines not cause disease
many reasons not known
some contain mutation in genome preventing them causing disease
how are killed vaccines created
killed by heating or exposure to chemicals e.g. formaldehyde
limitations of killed vaccines
more reactive
dont protect against inhaled infection
never contain V-antigen
killed vaccine
vaccine from dead microorganisms
generally used to provide immunization from organisms that are too virulent to be used in the living state
sub-unit vaccines
fragments of the microorganism e.g. proteins/poysccharides
examples of sub unit vaccines
diptheria
tetanus
anthrax
new plague
formation of subunit vaccines
identify key protective component
isolate genes encoding these components
produce component using genetic engineering
e.g. F1 and V-antigens